标题
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-11-13
DOI
10.3389/fphar.2018.01300
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
- (2018) E E Vokes et al. ANNALS OF ONCOLOGY
- Adverse Effects Associated with Clinical Applications of CAR Engineered T Cells
- (2018) Zohreh Sadat Badieyan et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer
- (2018) Lin-Lin Cao et al. BIOMETALS
- Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
- (2018) Volkmar Müller et al. BMC CANCER
- Cutaneous melanoma: From pathogenesis to therapy (Review)
- (2018) Giulia Leonardi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
- (2018) Federico Rossari et al. Journal of Hematology & Oncology
- DNA and chromosome damage induced by bleomycin in mammalian cells: An update
- (2018) Alejandro D. Bolzán et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- CRISPR/Cas9 for cancer research and therapy
- (2018) Tianzuo Zhan et al. SEMINARS IN CANCER BIOLOGY
- Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
- (2018) Izak Faiena et al. Drug Design Development and Therapy
- The development of CAR design for tumor CAR-T cell therapy
- (2018) Dandan Xu et al. Oncotarget
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Beginning the CAR T cell therapy revolution in the US and EU
- (2018) Stephan Grupp Current Research in Translational Medicine
- MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
- (2018) Rossella Salemi et al. Frontiers in Pharmacology
- Radiation fractionation: the search for isoeffect relationships and mechanisms
- (2017) John E. Moulder et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
- (2017) Jean-Sebastien Frenel et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
- (2017) Julie R Brahmer et al. LANCET ONCOLOGY
- Carfilzomib–dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study
- (2017) Hartmut Goldschmidt et al. LEUKEMIA & LYMPHOMA
- Phase I Dose-Escalation Study of Anti–CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers
- (2017) Divya Sakamuri et al. MOLECULAR CANCER THERAPEUTICS
- Proteasome inhibitors in cancer therapy
- (2017) Elisabet E. Manasanch et al. Nature Reviews Clinical Oncology
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy
- (2017) Lisa Rosenbaum NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
- (2017) Petros Fessas et al. SEMINARS IN ONCOLOGY
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Cyclophosphamide in dermatology
- (2016) Janet Kim et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pathfinders in oncology from ancient times to the end of the Middle Ages
- (2016) Steven I. Hajdu CANCER
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- The Roots of Modern Oncology: From Discovery of New Antitumor Anthracyclines to their Clinical Use
- (2016) Giuseppe Cassinelli TUMORI
- Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
- (2016) Lisa Deloch et al. Frontiers in Oncology
- The Roots of Modern Oncology: From Discovery of New Antitumor Anthracyclines to their Clinical Use
- (2016) Giuseppe Cassinelli TUMORI JOURNAL
- A dinosaurian facial deformity and the first occurrence of ameloblastoma in the fossil record
- (2016) Mihai D. Dumbravă et al. Scientific Reports
- A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
- (2015) Vakaramoko Diaby et al. BREAST CANCER RESEARCH AND TREATMENT
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeted therapy in cancer
- (2015) Apostolia-Maria Tsimberidou CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 5-Fluorouracil derivatives: a patent review (2012 – 2014)
- (2015) Esmeralda Carrillo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Surgical treatment of head and neck cancers in the ancient world
- (2015) J Kelly et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Remaining Mysteries of Molecular Biology: The Role of Polyamines in the Cell
- (2015) Leonor Miller-Fleming et al. JOURNAL OF MOLECULAR BIOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allosteric small-molecule kinase inhibitors
- (2015) Peng Wu et al. PHARMACOLOGY & THERAPEUTICS
- Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage
- (2015) Yulan Cheng et al. PLoS One
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization
- (2015) Lyubomyr Lytvynchuk et al. Journal of Ophthalmology
- Trastuzumab emtansine: mechanisms of action and drug resistance
- (2014) Mark Barok et al. BREAST CANCER RESEARCH
- Bevacizumab: A Review of Its Use in Advanced Cancer
- (2014) Gillian M. Keating DRUGS
- A brief history of cancer: Age-old milestones underlying our current knowledge database
- (2014) Guy B. Faguet INTERNATIONAL JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Emerging targeted therapies for melanoma treatment (Review)
- (2014) ANGELA RUSSO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Assessing Progress in Reducing the Burden of Cancer Mortality, 1985-2005
- (2014) Samir Soneji et al. JOURNAL OF CLINICAL ONCOLOGY
- Polyamine Transport Inhibitors: Design, Synthesis, and Combination Therapies with Difluoromethylornithine
- (2014) Aaron Muth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab
- (2014) Robert C. Quackenbush et al. LEUKEMIA & LYMPHOMA
- Antibodies directed against receptor tyrosine kinases
- (2014) Bénédicte FAUVEL et al. mAbs
- Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods
- (2014) Francisco D. C. Guerra Liberal et al. MEDICAL PHYSICS
- A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
- (2014) Ansgar Lange et al. BMC Pulmonary Medicine
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
- (2013) A. Schneeweiss et al. ANNALS OF ONCOLOGY
- HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
- (2013) Nadia Harbeck et al. Breast Care
- A note from history: Landmarks in history of cancer, Part 6
- (2013) Steven I. Hajdu et al. CANCER
- Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
- (2013) M. D. Wissing et al. CLINICAL CANCER RESEARCH
- Molecular radiotherapy
- (2013) J. Buscombe et al. CLINICAL MEDICINE
- From old alkylating agents to new minor groove binders
- (2013) Stéphane Puyo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Using cyclophosphamide in inflammatory rheumatic diseases
- (2013) Tobias Brummaier et al. European Journal of Internal Medicine
- The application of monoclonal antibodies in cancer diagnosis
- (2013) Xuemei Zhang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Antimetabolites: Established cancer therapy
- (2013) Manjul Tiwari Journal of Cancer Research and Therapeutics
- Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
- (2013) Sara A. Hurvitz et al. JOURNAL OF CLINICAL ONCOLOGY
- An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
- (2013) Melanie Poulin-Costello et al. Targeted Oncology
- Targeting mTOR Pathways in Human Malignancies
- (2012) Angelica Fasolo et al. CURRENT PHARMACEUTICAL DESIGN
- Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
- (2012) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
- (2012) E. B. Silberstein et al. JOURNAL OF NUCLEAR MEDICINE
- The contribution of Marie Skłodowska-Curie to the development of modern oncology
- (2011) Andrzej Kułakowski ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of mTOR inhibitor resistance in cancer therapy
- (2011) Jennifer S. Carew et al. Targeted Oncology
- Assessment of the Evolution of Cancer Treatment Therapies
- (2011) Manuel Arruebo et al. Cancers
- Ancient Greek and Greco–Roman Methods in Modern Surgical Treatment of Cancer
- (2010) Niki Papavramidou et al. ANNALS OF SURGICAL ONCOLOGY
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- A note from history: Landmarks in history of cancer, part 1
- (2010) Steven I. Hajdu CANCER
- Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations
- (2010) Shinji Sakaushi et al. CELL CYCLE
- CETUXIMAB: From Bench to Bedside
- (2010) B. Vincenzi et al. CURRENT CANCER DRUG TARGETS
- Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
- (2010) Ferdinand Sudbrock et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents
- (2009) Terence O’Reilly et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia
- (2009) D. Milojkovic et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
- (2009) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma
- (2008) Stephen M. Ansell et al. CANCER
- Oncophage: step to the future for vaccine therapy in melanoma
- (2008) Alessandra di Pietro et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients
- (2008) Edwin Herrmann et al. ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now